Corden Pharma Colorado, Inc.

Barry Thomas King

Richard A Gabel

Bradley S DeHoff

Paul Adam Bury

John Edward Crider

Robert Thad Carr, Ii

Robert Thad Carr Ii

The present invention relates to the preparation of insulinotropic peptides that are synthesized using a solid and solution phase ('hybrid') approach. Generally, the approach includes synthesizing three different peptide intermediate fragments using solid phase chemistry. Solution phase chemistry is then used to add additional amino acid material to one of the fragments. The fragments are then coupled together in the solution phase. The use of a pseudoproline in one of the fragments eases solid phase synthesis of that fragment and also eases subsequent solution phase coupling of this fragment to other fragments. The present invention is very useful for forming insulinotropic peptides such as Exenatide(1-39) and its natural and non-natural counterparts.

Growing community of inventors

Boulder, CO, United States of America

Barry Thomas King